Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunogenetics in SARS: a case-control study.
Ng MH, Cheng SH, Lau KM, Leung GM, Khoo US, Zee BC, Sung JJ. Ng MH, et al. Hong Kong Med J. 2010;16(5 Suppl 4):29-33. Hong Kong Med J. 2010. PMID: 20864745 No abstract available.
Evaluation of risk assessment tools and infectious aetiology in cancer patients with fever and neutropaenia in Hong Kong.
Hui EP, Leung LK, Mo F, Chan VT, Ma AT, Poon A, Hui EK, Mak SS, Lai M, Lei KI, Ma BB, Mok TS, Yeo W, Zee B, Chan AT. Hui EP, et al. Hong Kong Med J. 2010 Jun;16 Suppl 3:34-7. Hong Kong Med J. 2010. PMID: 20601732 No abstract available.
Role of laboratory variables in differentiating SARS-coronavirus from other causes of community-acquired pneumonia within the first 72 h of hospitalization.
Lee N, Rainer TH, Ip M, Zee B, Ng MH, Antonio GE, Chan E, Lui G, Cockram CS, Sung JJ, Hui DS. Lee N, et al. Eur J Clin Microbiol Infect Dis. 2006 Dec;25(12):765-72. doi: 10.1007/s10096-006-0222-z. Eur J Clin Microbiol Infect Dis. 2006. PMID: 17077967 Free PMC article.
Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.
Yeo W, Chan PK, Zhong S, Ho WM, Steinberg JL, Tam JS, Hui P, Leung NW, Zee B, Johnson PJ. Yeo W, et al. J Med Virol. 2000 Nov;62(3):299-307. doi: 10.1002/1096-9071(200011)62:3<299::aid-jmv1>3.0.co;2-0. J Med Virol. 2000. PMID: 11055239
High hepatitis B virus (HBV) DNA viral load is an important risk factor for HBV reactivation in breast cancer patients undergoing cytotoxic chemotherapy.
Zhong S, Yeo W, Schroder C, Chan PK, Wong WL, Ho WM, Mo F, Zee B, Johnson PJ. Zhong S, et al. J Viral Hepat. 2004 Jan;11(1):55-9. doi: 10.1046/j.1352-0504.2003.00467.x. J Viral Hepat. 2004. PMID: 14738558
Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.
Chan AT, Ma BB, Lo YM, Leung SF, Kwan WH, Hui EP, Mok TS, Kam M, Chan LS, Chiu SK, Yu KH, Cheung KY, Lai K, Lai M, Mo F, Yeo W, King A, Johnson PJ, Teo PM, Zee B. Chan AT, et al. J Clin Oncol. 2004 Aug 1;22(15):3053-60. doi: 10.1200/JCO.2004.05.178. J Clin Oncol. 2004. PMID: 15284255 Clinical Trial.
Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma.
Poon TC, Chan AT, Zee B, Ho SK, Mok TS, Leung TW, Johnson PJ. Poon TC, et al. Oncology. 2001;61(4):275-83. doi: 10.1159/000055334. Oncology. 2001. PMID: 11721174
Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma.
Yeo W, Mo FK, Koh J, Chan AT, Leung T, Hui P, Chan L, Tang A, Lee JJ, Mok TS, Lai PB, Johnson PJ, Zee B. Yeo W, et al. Ann Oncol. 2006 Jul;17(7):1083-9. doi: 10.1093/annonc/mdl065. Epub 2006 Apr 6. Ann Oncol. 2006. PMID: 16600982
84 results
Jump to page
Feedback